When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

The president’s Middle East visit produced multibillion-dollar technology investments by the Saudis and Emiratis. But they ...

LONDON (Reuters) -Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.